Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Felcoon Apr 02, 2014 12:53am
275 Views
Post# 22398984

RE:RE:RE:RE:RE:MS still sellling....

RE:RE:RE:RE:RE:MS still sellling....Perhaps it's time to turn the temperature on this board down just a bit.  While I agree, not every trading sequence which may raise an eyebrow is proof of malicious or nefarious intent, our friends at Morgan Stanley are a different matter.  I speak about it with my broker often.  I can tell you there's more than a couple of branch managers within the firm I'm with who think their trading practices need to be put under the microscope.  I'm not a conspiracy theorist, but in my books, their behavior is suspicious.  

With many institutions denied a neat and cheap eqity financing they were expecting about 15 months back, they've been forced to become creative.  After all, there's more than one way to skin a cat.  Or so I'm told.  Just my thoughts on the matter.

Good luck,
Felco
Bullboard Posts